Presentation is loading. Please wait.

Presentation is loading. Please wait.

Use of Recombinant Activated Factor VII Concentrate to Control Postoperative Hemorrhage in Complex Cardiovascular Surgery  Lyndsey J. Bowman, Walter E.

Published by진우 군 Modified over 5 years ago

Similar presentations

Presentation on theme: "Use of Recombinant Activated Factor VII Concentrate to Control Postoperative Hemorrhage in Complex Cardiovascular Surgery  Lyndsey J. Bowman, Walter E."— Presentation transcript:

1 Use of Recombinant Activated Factor VII Concentrate to Control Postoperative Hemorrhage in Complex Cardiovascular Surgery  Lyndsey J. Bowman, Walter E. Uber, Pharm D, Martha R. Stroud, Lydia R. Christiansen, John Lazarchick, Arthur J. Crumbley, MD, John M. Kratz, MD, John M. Toole, MD, Fred A. Crawford, MD, John S. Ikonomidis, MD, PhD  The Annals of Thoracic Surgery  Volume 85, Issue 5, Pages (May 2008) DOI: /j.athoracsur Copyright © 2008 The Society of Thoracic Surgeons Terms and Conditions

2 Fig 1 Transfusion requirements before (solid bars) recombinant activated factor VII administration and after (open bars) administration (n = 36). (Cryo = cryoprecipitate; FFP = fresh frozen plasma; RBC = red blood cells.) The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2008 The Society of Thoracic Surgeons Terms and Conditions

3 Fig 2 Chest tube output before (solid bars) recombinant activated factor VII (rFVIIa) administration (output averaged over 4 hours before receiving rFVIIa in the intensive care unit [ICU]) and after (open bars) administration (output averaged over 4 hours after receiving rFVIIa in the ICU). The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2008 The Society of Thoracic Surgeons Terms and Conditions

Download ppt "Use of Recombinant Activated Factor VII Concentrate to Control Postoperative Hemorrhage in Complex Cardiovascular Surgery  Lyndsey J. Bowman, Walter E."

Similar presentations

Antithrombin Administration in Patients With Low Antithrombin Values After Cardiac Surgery: A Randomized Controlled Trial  Domenico Paparella, MD, Crescenzia.

Antithrombin Administration in Patients With Low Antithrombin Values After Cardiac Surgery: A Randomized Controlled Trial  Domenico Paparella, MD, Crescenzia.
Twenty-Five Year Experience With the St

Twenty-Five Year Experience With the St
Major Bleeding, Transfusions, and Anemia: The Deadly Triad of Cardiac Surgery  Marco Ranucci, MD, FESC, Ekaterina Baryshnikova, BD, Serenella Castelvecchio,

Major Bleeding, Transfusions, and Anemia: The Deadly Triad of Cardiac Surgery  Marco Ranucci, MD, FESC, Ekaterina Baryshnikova, BD, Serenella Castelvecchio,
Effect of Hospital Culture on Blood Transfusion in Cardiac Procedures

Effect of Hospital Culture on Blood Transfusion in Cardiac Procedures
The STS National Database

The STS National Database
Contemporary Bloodletting in Cardiac Surgical Care

Contemporary Bloodletting in Cardiac Surgical Care
Warfarin therapy does not increase bleeding in patients undergoing heart transplantation  Cullen D Morris, MD, J.David Vega, MD, Jerrold H Levy, MD, Nancy.

Warfarin therapy does not increase bleeding in patients undergoing heart transplantation  Cullen D Morris, MD, J.David Vega, MD, Jerrold H Levy, MD, Nancy.
Implementation of a comprehensive blood conservation program can reduce blood use in a community cardiac surgery program  Steve Xydas, MD, Christopher.

Implementation of a comprehensive blood conservation program can reduce blood use in a community cardiac surgery program  Steve Xydas, MD, Christopher.
Robert Brewer, MD, MHSA, Patricia F. Theurer, BSN, Chad M

Robert Brewer, MD, MHSA, Patricia F. Theurer, BSN, Chad M
Gaetano Paone, MD, MHSA, Robert Brewer, MD, MHSA, Donald S

Gaetano Paone, MD, MHSA, Robert Brewer, MD, MHSA, Donald S
Robert J Cerfolio, MD, Cyndi Bass, MSN, Charles R Katholi, PhD 

Robert J Cerfolio, MD, Cyndi Bass, MSN, Charles R Katholi, PhD 
Platelet Transfusion in Cardiac Surgery Does Not Confer Increased Risk for Adverse Morbid Outcomes  Tory McGrath, MD, Colleen Gorman Koch, MD, MS, Meng.

Platelet Transfusion in Cardiac Surgery Does Not Confer Increased Risk for Adverse Morbid Outcomes  Tory McGrath, MD, Colleen Gorman Koch, MD, MS, Meng.
Age of Transfused Red Cells and Early Outcomes After Cardiac Surgery

Age of Transfused Red Cells and Early Outcomes After Cardiac Surgery
Analysis of Outcomes Using Low-Dose and Early Administration of Recombinant Activated Factor VII in Cardiac Surgery  Jason Brase, MS, Brooke Finger, MS,

Analysis of Outcomes Using Low-Dose and Early Administration of Recombinant Activated Factor VII in Cardiac Surgery  Jason Brase, MS, Brooke Finger, MS,
Long Esophageal Segment Laceration Caused by an Orogastric Tube During Laparoscopic Sleeve Gastrectomy  Sang Kuon Lee, MD, Jongho Lee, MD  The Annals.

Long Esophageal Segment Laceration Caused by an Orogastric Tube During Laparoscopic Sleeve Gastrectomy  Sang Kuon Lee, MD, Jongho Lee, MD  The Annals.
The Society of Thoracic Surgeons Thoracic Surgery Practice and Access Task Force: 2014 Workforce Report  John S. Ikonomidis, MD, PhD  The Annals of Thoracic.

The Society of Thoracic Surgeons Thoracic Surgery Practice and Access Task Force: 2014 Workforce Report  John S. Ikonomidis, MD, PhD  The Annals of Thoracic.
Burdens Without Blessings: Peer Reviewers Get No Respect

Burdens Without Blessings: Peer Reviewers Get No Respect
Emergency Coronary Artery Bypass Grafting Can Be Performed Safely Without Cardiopulmonary Bypass in Selected Patients  Faraz Kerendi, MD, John D. Puskas,

Emergency Coronary Artery Bypass Grafting Can Be Performed Safely Without Cardiopulmonary Bypass in Selected Patients  Faraz Kerendi, MD, John D. Puskas,
Off-Label Use of Recombinant Human Factor VIIa

Off-Label Use of Recombinant Human Factor VIIa
Susanne Lison, MD, Michael Spannagl, MD, PhD, Wulf Dietrich, MD, PhD 

Susanne Lison, MD, Michael Spannagl, MD, PhD, Wulf Dietrich, MD, PhD 

Similar presentations

Ads by Google